ANIMATION

HuLuc 63

PDL BioPharma asked XVIVO to show how a novel humanized antibody, HuLuc 63, appears to induce anti-tumor effects by binding to a protein expressed only on the surface of myeloma cells. This initiates antibody-dependent cytotoxic activity which targets myeloma cells while leaving healthy cells intact.

Client


PDL BioPharma

We have received a tremendously enthusiastic response from students, both in freshman biology and sophomore cell biology courses.

Robert Lue, Director of Life Sciences Education, Professor of the Practice of Molecular and Cellular Biology, Harvard University